| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Platelet membrane fluidity and platelet membrane lipid pattern in essential hypertension.
|
Am J Hypertens
|
1995
|
1.97
|
|
2
|
Essential hypertension: polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
|
Am J Hypertens
|
1999
|
1.40
|
|
3
|
Effects of exercise on inflammation markers in type 2 diabetic subjects.
|
Acta Diabetol
|
2011
|
0.98
|
|
4
|
Granulocyte integrins before and after activation in acute ischaemic stroke.
|
J Neurol Sci
|
2001
|
0.86
|
|
5
|
Haemorheological pattern in young adults with acute myocardial infarction.
|
Clin Hemorheol Microcirc
|
2003
|
0.80
|
|
6
|
Influence of a new bicycle crank design on aerobic parameters of non-cyclists.
|
J Sports Med Phys Fitness
|
2012
|
0.79
|
|
7
|
Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications.
|
Acta Diabetol
|
2003
|
0.78
|
|
8
|
Lipid peroxidation and protein oxidation are related to the severity of OSAS.
|
Eur Rev Med Pharmacol Sci
|
2014
|
0.77
|
|
9
|
Haemorheological profile in subjects with nonvalvular atrial fibrillation.
|
Clin Hemorheol Microcirc
|
1999
|
0.77
|
|
10
|
Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
|
Angiology
|
1996
|
0.77
|
|
11
|
Diabetes mellitus: mean erythrocyte aggregation, glycometabolic pattern, red cell Ca2+ content, and erythrocyte membrane dynamic properties.
|
Microvasc Res
|
1993
|
0.77
|
|
12
|
Deep venous thrombosis: leukocyte rheology at baseline and after in vitro activation.
|
Haemostasis
|
2001
|
0.77
|
|
13
|
Diabetes mellitus: polymorphonuclear leukocyte (PMN) filtration parameters and PMN membrane fluidity after chemotactic activation.
|
Metabolism
|
1999
|
0.76
|
|
14
|
Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications.
|
Diabetes Care
|
1995
|
0.76
|
|
15
|
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in diabetes mellitus.
|
Acta Diabetol
|
1998
|
0.76
|
|
16
|
Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.
|
Clin Hemorheol Microcirc
|
2015
|
0.75
|
|
17
|
Chronic renal failure: behaviour of the polymorphonuclear leukocyte membrane fluidity at baseline and after chemotactic activation.
|
Nephrol Dial Transplant
|
1999
|
0.75
|
|
18
|
Exercise test: trend of the leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in normals, in subjects with previous acute myocardial infarction and in subjects with aortocoronary by-pass.
|
Clin Hemorheol Microcirc
|
1997
|
0.75
|
|
19
|
Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
|
Thromb Haemost
|
1999
|
0.75
|
|
20
|
Essential hypertension: leukocyte rheology and polymorphonuclear cytosolic Ca2+ content at baseline and after activation.
|
Clin Hemorheol Microcirc
|
1998
|
0.75
|
|
21
|
Granulocyte rheology before and after chemotactic activation in deep venous thrombosis.
|
Clin Appl Thromb Hemost
|
2000
|
0.75
|
|
22
|
Deep venous thrombosis: behaviour of the polymorphonuclear leukocyte integrin pattern at baseline and after in vitro activation.
|
Clin Hemorheol Microcirc
|
2005
|
0.75
|
|
23
|
Chronic renal failure: leukocyte rheology and polymorphonuclear cytosolic Ca2+ concentration.
|
Curr Med Res Opin
|
1999
|
0.75
|
|
24
|
Type II diabetics with macrovascular complications: polymorphonuclear leukocyte (PMN) filtration, PMN membrane fluidity and cytosolic Ca2+ content after activation.
|
Horm Metab Res
|
1998
|
0.75
|
|
25
|
[Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
|
Recenti Prog Med
|
1995
|
0.75
|
|
26
|
Leukocyte rheology before and after chemotactic activation in some venous diseases.
|
Eur J Vasc Endovasc Surg
|
1999
|
0.75
|
|
27
|
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) content in young adults with acute myocardial infarction. Evaluation at the initial stage and after 12 months.
|
Clin Hemorheol Microcirc
|
2004
|
0.75
|
|
28
|
Leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in chronic renal failure.
|
Nephron
|
1996
|
0.75
|
|
29
|
Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease.
|
Thromb Haemost
|
2000
|
0.75
|
|
30
|
Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.
|
Hypertension
|
2000
|
0.75
|
|
31
|
Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction.
|
Clin Hemorheol Microcirc
|
2015
|
0.75
|
|
32
|
Beta-thromboglobulin and platelet factor 4 in juvenile myocardial infarction.
|
Clin Appl Thromb Hemost
|
2007
|
0.75
|
|
33
|
Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects.
|
Clin Hemorheol Microcirc
|
2016
|
0.75
|
|
34
|
Protein carbonyl groups in trained subjects.
|
Clin Hemorheol Microcirc
|
2012
|
0.75
|
|
35
|
Cytosolic Ca2+ content and membrane fluidity of platelets and polymorphonuclear leucocytes in diabetes mellitus.
|
Horm Metab Res
|
1995
|
0.75
|
|
36
|
Leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease.
|
Artery
|
1997
|
0.75
|
|
37
|
[Clinico-functional respiratory assessment of the athlete with exercise-induced asthma or bronchospasm].
|
Minerva Med
|
1998
|
0.75
|
|
38
|
[Deep vein thrombosis: leukocyte rheology, membrane fluidity and cytosol calcium of polymorphonucleocytes before and after activation].
|
Minerva Cardioangiol
|
1998
|
0.75
|
|
39
|
Exercise test: leukocyte rheology and polymorphonuclear cystolic Ca2+ content in normals and in subjects submitted to coronary angioplasty.
|
Clin Hemorheol Microcirc
|
1998
|
0.75
|
|
40
|
Erythrocyte membrane protein lateral mobility in chronic renal failure.
|
Nephron
|
1999
|
0.75
|
|
41
|
Polymorphonuclear leukocyte integrins in deep venous thrombosis.
|
Clin Appl Thromb Hemost
|
2005
|
0.75
|
|
42
|
Polymorphonuclear cytosolic Ca(2+) concentration before and after activation in chronic renal failure.
|
Nephron
|
2000
|
0.75
|
|
43
|
Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
|
Clin Hemorheol Microcirc
|
2004
|
0.75
|
|
44
|
Behavior of the polymorphonuclear leukocyte membrane fluidity and cystolic Ca2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus.
|
Clin Hemorheol Microcirc
|
1998
|
0.75
|
|
45
|
Erythrocyte membrane fluidity and red cell cytosolic Ca2+ content during incubation, in normals and in subjects with vascular atherosclerotic disease and non-insulin-dependent diabetes mellitus.
|
Clin Hemorheol Microcirc
|
1998
|
0.75
|
|
46
|
Acute ischemic stroke : polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) concentration at baseline and after chemotactic activation.
|
Stroke
|
2000
|
0.75
|
|
47
|
Use of QT intervals for a more accurate diagnose of syncope and evaluation of syncope severity.
|
Int J Clin Pract
|
2014
|
0.75
|
|
48
|
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content in different clinical conditions.
|
Clin Hemorheol Microcirc
|
1997
|
0.75
|
|
49
|
Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance.
|
Acta Diabetol
|
2000
|
0.75
|